Showing results (1381-1390 of 3,550) with videos related to

Sort By:
Pageof 355
Thoracic Cancer|November 25, 2021
Onset of pulmonary Epstein-Barr virus-positive diffuse large B-cell lymphoma in a patient with silicosisRyosuke Ogata, Hiroshi Soda, Yasuhiro Tanaka, et al.
Thoracic Cancer|January 11, 2022
Metastatic pulmonary nodule after a seventeen-year disease-free interval resected through thoracoscopic subsegmentectomy: A case reportTsuyoshi Uchida, Hirochika Matsubara, Daisuke Sato, et al.
Thoracic Cancer|January 14, 2022
Apatinib as maintenance therapy following standard first-line chemotherapy in extensive disease small cell lung cancer: A phase II single-arm trialFei Teng, Puyuan Xing, Ke Yang, et al.
Thoracic Cancer|January 19, 2022
Circ_0007580 knockdown strengthens the radiosensitivity of non-small cell lung cancer via the miR-598-dependent regulation of THBS2Zheng Yang, Hongfang Wu, Kai Zhang, et al.
Thoracic Cancer|January 21, 2022
Local consolidative therapy for synchronous oligometastatic non-small cell lung cancer treated with first-line pembrolizumab: A retrospective observational studyYa Chen, Yanan Wang, Zhengyu Yang, et al.
Thoracic Cancer|November 6, 2021
Diagnostic performance of SHOX2 promoter methylation as biomarker for lung cancer identification: A meta-analysis updateXiaoxi Zhou, Xiaoling Lu, Haiyan Wu, et al.
Thoracic Cancer|November 6, 2021
Circular RNA circCPA4 promotes tumorigenesis by regulating miR-214-3p/TGIF2 in lung cancerWenhu Tao, Cheng Cao, Gaofei Ren, et al.
Thoracic Cancer|February 24, 2021
Durvalumab-induced lesions of bronchiolitis and fully reversible bronchiectasis in a patient with non-small cell lung cancer: A case reportMaël Domblides, Margaux Geier, Chantal Decroisette, et al.
Thoracic Cancer|December 3, 2021
A case of pulmonary pleomorphic carcinoma with preexisting interstitial pneumonia successfully treated with pembrolizumabMasahiro Sako, Hiroshi Nokihara, Kensuke Kondo, et al.
Thoracic Cancer|December 9, 2021
Multicenter real-world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non-small cell lung cancerSu Yeon Lee, Young Chul Kim, Kye Young Lee, et al.
Pageof 355